Biotron Ltd (BIT) - Financial and Strategic SWOT Analysis Review

October 2021 | 33 pages | ID: BAEBE11FAF8EN
GlobalData

Abstracts

Biotron Ltd (BIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Biotron Ltd (Biotron) is a clinical stage biotechnology company develops novel small molecule antiviral therapeutics for the treatment of infectious diseases such as hepatitis C virus (HCV) and HIV-1. Biotron’s core focus is to design and develop drugs that target a new class of viral proteins (viroporins). The company’s lead drug candidate, BIT225 is in Phase II clinical trials for the treatment of both HIV-1 and Hepatitis C virus (HCV). Biotron also has other preclinical programs targeting infectious diseases such as dengue, Zika and Hepatitis B. It holds patents for drug candidates in various countries including Australia, Canada, China, Europe, Japan, New Zealand, the US and other countries. Biotron is headquartered in Sydney, New South Wales, Australia.

Biotron Ltd Key Recent Developments

Apr 28,2021: Report on activities for the quarter ended 31 march 2021

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Biotron Ltd - Key Facts
Biotron Ltd - Key Employees
Biotron Ltd - Key Employee Biographies
Biotron Ltd - Major Products and Services
Biotron Ltd - History
Biotron Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Biotron Ltd - Business Description
Biotron Ltd - SWOT Analysis
SWOT Analysis - Overview
Biotron Ltd - Strengths
Biotron Ltd - Weaknesses
Biotron Ltd - Opportunities
Biotron Ltd - Threats
Biotron Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Biotron Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Biotron Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Biotron Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Apr 28, 2021: Report on activities for the quarter ended 31 march 2021

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Biotron Ltd, Key Facts
Biotron Ltd, Key Employees
Biotron Ltd, Key Employee Biographies
Biotron Ltd, Major Products and Services
Biotron Ltd, History
Biotron Ltd, Other Locations
Biotron Ltd, Key Competitors
Biotron Ltd, Ratios based on current share price
Biotron Ltd, Annual Ratios
Biotron Ltd, Annual Ratios (Cont...1)
Biotron Ltd, Interim Ratios
Biotron Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Biotron Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Biotron Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Biotron Ltd, Performance Chart (2017 - 2021)
Biotron Ltd, Ratio Charts
Biotron Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Biotron Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021